Blog
RSS FeedPosted by Michael Wonder on 18 Jun 2021
Let's have permanently quicker drug approvals
16 June 2021 - New drugs and vaccines likely to increase life expectancy, quality of life and save money, so we ...
Posted by Michael Wonder on 17 Jun 2021
A life-saving new drug for COVID-19 is found
16 June 2021 - But only rich countries will benefit, and even they will struggle to get hold of it. ...
Posted by Michael Wonder on 17 Jun 2021
Expanded PBS listing to save Australians around $120,000 a year
17 June 2021 - More than 800 Australians with stage IV advanced or metastatic kidney cancer will now have improved access ...
Posted by Michael Wonder on 16 Jun 2021
Medicare must study unproven, expensive Alzheimer’s drug
15 June 2021 - Tax payers and patients cannot afford to pay a high price for a treatment not known to ...
Posted by Michael Wonder on 13 Jun 2021
Unaffordable treatment for severe malaria highlights U.S. drug market pitfalls
11 June 2021 - When Eli Lilly announced in 2017 that it would stop producing quinidine, it was the only ...
Posted by Michael Wonder on 11 Jun 2021
PHARMAC’s decision over diabetes drugs could see up to 140,000 ‘miss out’, doctor says
11 June 2021 - Dr John Baker, the chair of the Diabetes Foundation Aotearoa, says that has to change and highlights ...
Posted by Michael Wonder on 09 Jun 2021
Stop blaming PHARMAC - we'd be worse off without it
10 June 2021 - Penny Tucker is concerned that there are “miracle drugs and biologics that have transformed many conditions ...
Posted by Michael Wonder on 09 Jun 2021
Alzheimer’s drug is bonanza for Biogen, most likely at taxpayer expense
8 June 2021 - The FDA’s decision on Monday to approve a new Alzheimer’s medication over the fierce objections of ...
Posted by Michael Wonder on 09 Jun 2021
Amicus Therapeutics announces United Kingdom’s MHRA grants early access to AT-GAA
8 June 2021 - Permits All Eligible Individuals with Late-Onset Pompe Disease Access to AT-GAA Prior to Marketing Authorization in the ...
Posted by Michael Wonder on 08 Jun 2021
Biogen and Eisai launch multiple initiatives to help patients with Alzheimer’s disease access Aduhelm
7 June 2021 - Value based agreements in progress with Cigna and other payers. ...
Posted by Michael Wonder on 08 Jun 2021
Robertson says PHARMAC's bulk buying model is 'different', not 'worse' than other OECD countries
8 June 2021 - The Deputy Prime Minister says the agency’s bulk buying model works for many Kiwis. ...
Posted by Michael Wonder on 07 Jun 2021
Limiting coverage based on efficacy and safety: a path forward for Medicare regarding the Alzheimer’s treatment aducanumab
7 June 2021 - Today, the FDA will announce a decision on whether to approve the biologic aducanumab, intended to alleviate ...
Posted by Michael Wonder on 07 Jun 2021
Safer and more effective shingles vaccine will be available to Aussies - but it won’t come cheap
8 June 2021 - A new shingles vaccine almost twice as effective as the one currently available to Australians will ...
Posted by Michael Wonder on 05 Jun 2021
Newly approved obesity drug Wegovy holds promise, but faces reimbursement challenges
5 June 2021 - On 4 June, the FDA approved Novo Nordisk’s obesity drug Wegovy (semaglutide), a glucagon-like peptide 1 receptor ...
Posted by Michael Wonder on 03 Jun 2021
Most Americans support Medicare negotiation despite claims it would hurt innovation
3 June 2021 - A new West Health/Gallup survey finds nearly all Democrats (97%) and the majority of Republicans (61%) support ...